A detailed history of Wellington Management Group LLP transactions in Zai Lab LTD stock. As of the latest transaction made, Wellington Management Group LLP holds 8,436,606 shares of ZLAB stock, worth $221 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
8,436,606
Previous 7,124,491 18.42%
Holding current value
$221 Million
Previous $123 Million 64.95%
% of portfolio
0.04%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$16.25 - $24.14 $21.3 Million - $31.7 Million
1,312,115 Added 18.42%
8,436,606 $204 Million
Q2 2024

Aug 13, 2024

BUY
$13.72 - $21.55 $6.41 Million - $10.1 Million
466,842 Added 7.01%
7,124,491 $123 Million
Q1 2024

May 15, 2024

BUY
$15.95 - $26.8 $106 Million - $178 Million
6,657,649 New
6,657,649 $107 Million
Q4 2023

Feb 12, 2024

BUY
$22.97 - $30.58 $123 Million - $163 Million
5,336,457 New
5,336,457 $146 Million
Q3 2023

Nov 14, 2023

SELL
$22.72 - $31.49 $3.47 Million - $4.81 Million
-152,724 Reduced 7.36%
1,922,628 $46.7 Million
Q2 2023

Aug 14, 2023

BUY
$25.3 - $39.67 $19.2 Million - $30.2 Million
760,307 Added 57.82%
2,075,352 $57.5 Million
Q1 2023

May 12, 2023

BUY
$30.21 - $48.1 $1.08 Million - $1.72 Million
35,678 Added 2.79%
1,315,045 $43.7 Million
Q4 2022

Feb 13, 2023

BUY
$22.28 - $38.71 $214,957 - $373,474
9,648 Added 0.76%
1,279,367 $39.3 Million
Q3 2022

Nov 14, 2022

BUY
$34.2 - $51.69 $5.6 Million - $8.47 Million
163,803 Added 14.81%
1,269,719 $43.4 Million
Q2 2022

Aug 15, 2022

SELL
$23.14 - $49.68 $347,979 - $747,087
-15,038 Reduced 1.34%
1,105,916 $38.4 Million
Q1 2022

May 16, 2022

SELL
$27.77 - $64.4 $67.4 Million - $156 Million
-2,427,161 Reduced 68.41%
1,120,954 $49.3 Million
Q4 2021

Feb 11, 2022

SELL
$54.9 - $105.21 $3.14 Million - $6.02 Million
-57,175 Reduced 1.59%
3,548,115 $223 Million
Q3 2021

Nov 15, 2021

BUY
$105.0 - $178.37 $15.3 Million - $25.9 Million
145,394 Added 4.2%
3,605,290 $380 Million
Q2 2021

Aug 16, 2021

BUY
$125.11 - $180.0 $170 Million - $245 Million
1,361,844 Added 64.91%
3,459,896 $612 Million
Q1 2021

May 17, 2021

SELL
$126.27 - $191.71 $27.4 Million - $41.6 Million
-216,968 Reduced 9.37%
2,098,052 $280 Million
Q4 2020

Feb 12, 2021

SELL
$81.94 - $135.34 $4.53 Million - $7.48 Million
-55,287 Reduced 2.33%
2,315,020 $313 Million
Q3 2020

Nov 16, 2020

SELL
$73.3 - $89.48 $16.2 Million - $19.7 Million
-220,541 Reduced 8.51%
2,370,307 $197 Million
Q2 2020

Aug 14, 2020

SELL
$48.82 - $82.53 $7.75 Million - $13.1 Million
-158,729 Reduced 5.77%
2,590,848 $213 Million
Q1 2020

May 14, 2020

SELL
$39.1 - $62.9 $3.53 Million - $5.68 Million
-90,270 Reduced 3.18%
2,749,577 $142 Million
Q4 2019

Feb 11, 2020

BUY
$29.79 - $43.06 $84.6 Million - $122 Million
2,839,847 New
2,839,847 $118 Million

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.56B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.